While a data misstep would fit well into certain narratives, it appears unlikely that an accurate positivity rate or other metrics would have changed the outcome in the Pac-12.
For starters, a member of the conference’s medical advisory group told Oregon Live that there still would have been a delay:
“The data presented by the Pac-12 COVID-19 Medical Advisory Committee to the CEO Group was accurately sourced at the time,” Dr. Kim Harmon, associate team physician at the University of Washington, said Thursday in a statement via the Pac-12 to The Oregonian/OregonLive. “To the extent that there were subsequent updates to the reported data by COVID Act Now, state or local dashboards, they would not have changed the overarching recommendation of the Medical Advisory Committee to the CEO Group.”
The prevalence of COVID-19 in the Pac-12’s communities was also just one of three official considerations for the Pac-12.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.